Yetian Dong

666 total citations
7 papers, 442 citations indexed

About

Yetian Dong is a scholar working on Infectious Diseases, Oncology and Epidemiology. According to data from OpenAlex, Yetian Dong has authored 7 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 2 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in Yetian Dong's work include SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 Clinical Research Studies (3 papers) and Viral gastroenteritis research and epidemiology (2 papers). Yetian Dong is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 Clinical Research Studies (3 papers) and Viral gastroenteritis research and epidemiology (2 papers). Yetian Dong collaborates with scholars based in China, South Korea and United States. Yetian Dong's co-authors include Long Zhang, Fangfang Zhou, Tong Dai, Min Zheng, Yujun Wei, Lei Zhang, Haiyan Yan, Jun Huang, Bin Wang and Linghui Zeng and has published in prestigious journals such as Blood, Advanced Science and Signal Transduction and Targeted Therapy.

In The Last Decade

Yetian Dong

6 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yetian Dong China	4	366	105	65	62	44	7	442
Pinkus Tober‐Lau Germany	11	429 1.2×	158 1.5×	46 0.7×	72 1.2×	56 1.3×	27	581
Martin Lier Germany	5	533 1.5×	134 1.3×	41 0.6×	66 1.1×	54 1.2×	8	607
Sandra Hauka Germany	5	406 1.1×	61 0.6×	66 1.0×	39 0.6×	42 1.0×	7	473
Juanita Mellet South Africa	9	274 0.7×	96 0.9×	51 0.8×	73 1.2×	32 0.7×	22	443
John C. Prostko United States	8	481 1.3×	50 0.5×	65 1.0×	61 1.0×	60 1.4×	20	540
Adam Brosz United States	4	363 1.0×	89 0.8×	79 1.2×	54 0.9×	24 0.5×	4	399
Nichole McGhee United States	3	357 1.0×	88 0.8×	79 1.2×	54 0.9×	23 0.5×	3	393
Ying Chang United States	5	442 1.2×	107 1.0×	91 1.4×	72 1.2×	25 0.6×	6	490
Shannon C. Walker United States	6	225 0.6×	62 0.6×	51 0.8×	40 0.6×	26 0.6×	13	338
Lin‐Lei Chen Hong Kong	10	418 1.1×	100 1.0×	23 0.4×	50 0.8×	44 1.0×	20	520

Countries citing papers authored by Yetian Dong

Since Specialization

Citations

This map shows the geographic impact of Yetian Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yetian Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yetian Dong more than expected).

Fields of papers citing papers by Yetian Dong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yetian Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yetian Dong. The network helps show where Yetian Dong may publish in the future.

Co-authorship network of co-authors of Yetian Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Yetian Dong. A scholar is included among the top collaborators of Yetian Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yetian Dong. Yetian Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Yang, Tingting, Yetian Dong, Mingming Zhang, et al.. (2025). Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia. Experimental Hematology and Oncology. 14(1). 2–2. 3 indexed citations

2.

Dong, Yetian, Zhengde Xie, & Lili Xu. (2025). Receptors and host factors: key players in human metapneumovirus infection. Frontiers in Cellular and Infection Microbiology. 15. 1557880–1557880. 6 indexed citations

3.

Yang, Tingting, Yetian Dong, Mingming Zhang, et al.. (2024). Sequential CD19 and CD22 CAR-T Therapy in Relapsed/Refractory Acute Lymphoblastic Leukemia. Blood. 144(Supplement 1). 2818–2818. 1 indexed citations

4.

Zu, Cheng, et al.. (2024). Outcome of Pneumocystis Jirovecii pneumonia (PcP) in post-CAR-T patients with hematological malignancies. BMC Infectious Diseases. 24(1). 1147–1147.

5.

Dong, Yetian, Tong Dai, Bin Wang, et al.. (2021). The way of SARS-CoV-2 vaccine development: success and challenges. Signal Transduction and Targeted Therapy. 6(1). 387–387. 33 indexed citations

6.

Dong, Yetian, Tong Dai, Jun Liu, Long Zhang, & Fangfang Zhou. (2020). Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2. Advanced Science. 7(20). 2001474–2001474. 16 indexed citations

7.

Dong, Yetian, Tong Dai, Yujun Wei, et al.. (2020). A systematic review of SARS-CoV-2 vaccine candidates. Signal Transduction and Targeted Therapy. 5(1). 237–237. 383 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact